Genesis Healthcare Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
10
Price Target
$25.00
Consensus
Outperform
Upside
17.37%
Analysts
2
Stock Rating
10
Upside
17.37%
Analysts
2
Price Target
$25.00

Genesis Healthcare Inc Stock Forecast and Price Target

If the average price target of $25.00 set by two distinguished experts for Genesis Healthcare Inc over the past few weeks is reached this year, there would be a potential upside of approximately 17.37% from the last closing price in February, 2023. This potential increase is based on a high estimate of $29.00 and a low estimate of $24.00. Even if not interested in GEN stock, you may want to be aware of its competitors.

$25.00

17.37% Upside

Outperform
Outperform

Genesis Healthcare Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Price has grown from $24.07 to $26.50 – a 10.06% increase. Next year, analysts are expecting Fair Value to reach $28.77 – an increase of 8.57%. Over the next eight years, the forecast is for Fair Value to grow by 24.89%.

2023 Fair Value Forecast
$28.77
2024 Fair Value Forecast
$31.19
2025 Fair Value Forecast
$29.52
2026 Fair Value Forecast
$34.22
2027 Fair Value Forecast
$35.28
2028 Fair Value Forecast
$33.97
2029 Fair Value Forecast
$32.51
2030 Fair Value Forecast
$33.09
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
MSFT Stock Forecast Microsoft Outperform 18
$258.35 $285.81 8.38%
CRM Stock Forecast salesforce.com, inc. Outperform 16
$171.04 $189.99 8.16%
INTU Stock Forecast Intuit Outperform 10
$423.76 $476.40 11.86%
NOW Stock Forecast ServiceNow Buy 14
$472.22 $521.22 8.00%
ATVI Stock Forecast Activision Blizzard Outperform 17
$75.24 $92.04 26.26%

Genesis Healthcare Inc Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Revenue has grown from $2.46B to $2.80B – a 13.84% increase. Next year, analysts are expecting Revenue to reach $2.98B – an increase of 6.71%. Over the next eight years, the forecast is for Revenue to grow by 18.22%.

2023 Rev Forecast
$2.98B
2024 Rev Forecast
$3.17B
2025 Rev Forecast
$3.12B
2026 Rev Forecast
$3.37B
2027 Rev Forecast
$3.44B
2028 Rev Forecast
$3.35B
2029 Rev Forecast
$3.27B
2030 Rev Forecast
$3.31B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
SNPS Stock Forecast Synopsys Buy 16
$361.44 $414.43 16.20%
EA Stock Forecast Electronic Arts Outperform 16
$113.92 $148.57 31.67%
NUAN Stock Forecast Nuance Communications - 12
$55.99 $57.00 -62.49%

Genesis Healthcare Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Dividend per Share has grown by 66.67%, rising from $0.30 to $0.50. According to 2 prominent analysts, Genesis Healthcare Inc's Dividend per Share will fall by 0.00% in the next year, reaching $0.50. Over the next eight years, experts predict that Genesis Healthcare Inc's Dividend per Share will grow at a rate of 2.53%.

2023 DPS Forecast
$0.50
2024 DPS Forecast
$0.50
2025 DPS Forecast
$0.50
2026 DPS Forecast
$0.52
2027 DPS Forecast
$0.52
2028 DPS Forecast
$0.51
2029 DPS Forecast
$0.51
2030 DPS Forecast
$0.51
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
TTWO Stock Forecast Take-Two Interactive Software Outperform 12
$109.28 $136.07 20.79%
PTC Stock Forecast PTC Outperform 15
$130.55 $142.86 11.07%
SPLK Stock Forecast Splunk Outperform 7
$104.57 $123.41 4.24%

Genesis Healthcare Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Free Cash Flow has seen a drop from $1.29B to $968.00M – a 24.84% decrease. In the next year, analysts believe that Free Cash Flow will reach $1.17B – an increase of 21.18%. For the next eight years, the forecast is for Free Cash Flow to grow by 27.09%.

2023 FCF Forecast
$1.17B
2024 FCF Forecast
$1.34B
2025 FCF Forecast
$1.15B
2026 FCF Forecast
$1.21B
2027 FCF Forecast
$1.25B
2028 FCF Forecast
$1.29B
2029 FCF Forecast
$1.24B
2030 FCF Forecast
$1.23B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
SSNC Stock Forecast SS&C Technologies Holdings Outperform 18
$61.62 $65.55 5.49%
CTXS Stock Forecast Citrix Systems - 13
$103.90 $105.86 -1.59%
NasdaqGS:AZPN Stock Forecast AspenTech - 16
$166.30 $152.67 49.75%

Genesis Healthcare Inc Net Income Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Net Income has grown by 2596.77%, rising from $31.00M to $836.00M. For next year, analysts predict Net Income of $1.11B, which would mean an increase of 32.94%. Over the next eight years, experts predict that Genesis Healthcare Inc's Net Income will grow at a rate of 51.62%.

2023 NI Forecast
$1.11B
2024 NI Forecast
$1.20B
2025 NI Forecast
$1.20B
2026 NI Forecast
$1.30B
2027 NI Forecast
$1.32B
2028 NI Forecast
$1.28B
2029 NI Forecast
$1.25B
2030 NI Forecast
$1.27B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
PFPT Stock Forecast Proofpoint - 10
$175.90 $172.31 2.03%
ZNGA Stock Forecast Zynga Hold 14
$8.18 $12.04 22.25%
CHNG Stock Forecast Change Healthcare Hold 11
$27.49 $0.00 -6.33%

Genesis Healthcare Inc EBITDA Forecast for 2023 - 2025 - 2030

Genesis Healthcare Inc's EBITDA has grown In the last three years, rising from $596.00M to $1.32B – a growth of 121.81%. In the next year, analysts believe that EBITDA will reach $1.56B – an increase of 17.82%. For the next eight years, experts predict that Genesis Healthcare Inc's EBITDA will grow at a rate of 28.94%.

2023 EBITDA Forecast
$1.56B
2024 EBITDA Forecast
$1.65B
2025 EBITDA Forecast
$1.67B
2026 EBITDA Forecast
$1.71B
2027 EBITDA Forecast
$1.75B
2028 EBITDA Forecast
$1.71B
2029 EBITDA Forecast
$1.70B
2030 EBITDA Forecast
$1.70B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
RP Stock Forecast RealPage - 16
$0.13 $94.88 74023.08%
GWRE Stock Forecast Guidewire Software Outperform 2
$75.80 $79.58 7.52%
NATI Stock Forecast National Instruments Outperform 18
$53.50 $48.29 -10.28%

Genesis Healthcare Inc EBIT Forecast for 2023 - 2025 - 2030

Genesis Healthcare Inc's EBIT has seen impressive growth In the last three years, rising from $379.00M to $1.22B – a growth of 222.16%. In the next year, analysts believe that EBIT will reach $1.56B – an increase of 27.78%. For the next eight years, the forecast is for EBIT to grow by 32.17%.

2023 EBIT Forecast
$1.56B
2024 EBIT Forecast
$1.68B
2025 EBIT Forecast
$1.66B
2026 EBIT Forecast
$1.56B
2027 EBIT Forecast
$1.60B
2028 EBIT Forecast
$1.63B
2029 EBIT Forecast
$1.64B
2030 EBIT Forecast
$1.61B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ESTC Stock Forecast Elastic N.V. Outperform 8
$61.30 $0.00 109.62%
QLYS Stock Forecast Qualys Hold 16
$122.97 $140.27 2.06%
ALTR Stock Forecast Altair Engineering Outperform 15
$57.77 $0.00 45.40%

Genesis Healthcare Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's EPS has grown from $1.59 to $1.75 – a 10.06% increase. Next year, analysts are expecting EPS to reach $1.90 – an increase of 8.57%. Over the next eight years, the forecast is for EPS to grow by 24.89%.

2023 EPS Forecast
$1.90
2024 EPS Forecast
$2.06
2025 EPS Forecast
$1.95
2026 EPS Forecast
$2.26
2027 EPS Forecast
$2.33
2028 EPS Forecast
$2.24
2029 EPS Forecast
$2.15
2030 EPS Forecast
$2.19
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ALU Stock Forecast Altium Hold 18
$167.50 $31.62 -79.70%
NCR Stock Forecast NCR Buy 15
$28.39 $53.86 51.46%
PEGA Stock Forecast Pegasystems Hold 8
$40.98 $58.00 22.01%